Cargando…
The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
Over the past ∼15 years there has been great progress in our understanding of the genetics of both type 1 diabetes and type 2 diabetes. This has been driven principally by genome-wide association studies (GWAS) in increasingly larger sample sizes, where many distinct loci have now been reported for...
Autor principal: | Grant, Struan F.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702598/ https://www.ncbi.nlm.nih.gov/pubmed/31409726 http://dx.doi.org/10.2337/dci19-0001 |
Ejemplares similares
-
The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021) -
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
por: Eckel, Robert H., et al.
Publicado: (2015) -
Understanding the Elusive Mechanism of Action of TCF7L2 in Metabolism
por: Grant, Struan F.A.
Publicado: (2012) -
The TCF7L2 locus and type 1 diabetes
por: Qu, Hui-Qi, et al.
Publicado: (2007) -
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)